Thursday, October 16, 2025

The Daily Chronicle

Bringing you the world's news since 1892
| health | agenda announced for 2026 mda ...

Agenda Announced for 2026 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease

Agenda Announced for 2026 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease

New York, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the agenda including tracks and chairs for the 2026 MDA Clinical & Scientific Conference being held March 8-11, 2026, in Orlando, Florida. Read the full agenda here.

Read Full Article
National Dessert Day puts America’s love of sweets in the spotlight

National Dessert Day puts America’s love of sweets in the spotlight

Bicycle Health Grows Leadership Team to Further Expand Access to Opioid Use Disorder Care for Patients in the Criminal Justice System

First-of-Its-Kind Study Reveals What It Takes for Physicians to Trust AI Diagnostics

First-of-Its-Kind Study Reveals What It Takes for Physicians to Trust AI Diagnostics

Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025

Peer Reviewed Publication Provides Evidence for Iron Dysregulation as a Driver of Dry AMD/GA and the Potential of Transferrin to Restore Iron Balance, Reinforcing PulseSight’s Therapeutic Strategy for PST-611

Argentina gets $20B while health care suffers

Argentina gets $20B while health care suffers

Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight

Column: Allergies aren't just for summer

Column: Allergies aren't just for summer

Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

9 fall casseroles so good you’ll crave them always

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology

4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation

Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

I’m a spine surgeon — this is absolutely the worst thing you can do for your neck and back

I’m a spine surgeon — this is absolutely the worst thing you can do for your neck and back

More Texas kindergarteners are coming to school without measles vaccination proof or exemptions - The Texas Tribune

bioLytical's iStatis Syphilis Antibody Test Now Included in the Australian Register of Therapeutic Goods (ARTG)